The quest for a single-pill once-a-day treatment for HIV became a reality when the FDA approved Atripla on July 12. It combines the already approved drugs efavirenz (Sustiva), tenofovir (Viread), and ...

Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

HUNTSVILLE, AL (WAFF) - Sept. 18 marks National HIV/AIDS and Aging Awareness Day. Older Americans are more likely than younger Americans to be diagnosed with HIV infection late in the course of their ...

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.

(Reuters) -Gilead Sciences said on Thursday a late-stage study showed its long-acting injectable drug was more effective in preventing HIV infection in women compared to its existing daily pill ...

HIV pill proves promising in new study, protects 100% of participants A study from Kaiser Permanente San Francisco Medical Center that examined the efficacy of preexposure prophylaxis, or PrEP, to ...

Charlie Sheen reveals he once used an experimental HIV drug called PRO 140 that he says worked better than standard treatment ...

Please provide your email address to receive an email when new articles are posted on . For the first time, adolescents with HIV have the option of a two-drug, single-tablet oral treatment regimen.